Parkman Healthcare Partners LLC Lantheus Holdings, Inc. Transaction History

Parkman Healthcare Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $1.67 Million - $2.35 Million	30,111 Added 60.36%	80,000 $4.96 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $11.8 Million - $17.8 Million	-195,658 Reduced 79.68%	49,889 $3.47 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $4.81 Million - $5.82 Million	58,360 Added 31.18%	245,547 $20.6 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $4.6 Million - $7.98 Million	96,264 Added 105.87%	187,187 $15.5 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $2.5 Million - $3.98 Million	51,241 Added 129.13%	90,923 $4.63 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $1.12 Million - $1.58 Million	18,255 Added 85.2%	39,682 $2.79 Million
Q2 2022 Aug 12, 2022	SELL	$55.54 - $72.65 $214,828 - $281,010	-3,868 Reduced 15.29%	21,427 $1.42 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $614,162 - $1.43 Million	25,295 New	25,295 $1.4 Million

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.